1
关注
911
浏览

为什么审查电子数据很重要?

查看全部 1 个回答

trer234 一阶会员 用户来自于: 广东省深圳市
2023-10-26 22:45

  In the case of data generated from an electronic system, electronic data is the original record which must be reviewed and evaluated prior to making batch release decisions and other decisions relating to GMP related activities (e.g. approval of stability results, analytical method validation etc.). In the event that the review is based solely on printouts there is potential for records to be excluded from the review process which may contain un-investigated out of specification data or other data anomalies. The review of the raw electronic data should mitigate risk and enable detection of data deletion, amendment, duplication, reusing and fabrication which are common data integrity failures. Example of an inspection citing:

在电子系统产生的数据的情况下,电子数据是原始记录,在作出批量放行决定和其他与GMP相关活动(如稳定性结果的批准、分析方法的验证等)的决定之前,必须对其进行审查和评估。如果审查只基于打印件,则有可能将可能包含未调查的超规格数据或其他数据异常的记录排除在审查过程之外。对原始电子数据的审查应能降低风险,并能发现数据的删除、修改、复制、重复使用和捏造等常见的数据完整性故障。检查的例子引证。

Raw data for HPLC/GC runs which had been invalidated was stored separately to the QC raw data packages and had not been included in the review process.

已经失效的HPLC/GC运行的原始数据与QC原始数据包分开保存,没有被纳入审查过程。

In the above situation, the procedure for review of chromatographic data packages did not require a review of the electronic raw data or a review of relevant audit trails associated with the analyses. This lead to the exclusion of records from the review process and to lack of visibility of changes made during the processing and reporting of the data. The company was unable to provide any explanation for the data which had been invalidated.

在上述情况下,对色谱数据包的审查程序没有要求审查电子原始数据或审查与分析有关的相关审计跟踪。这导致审查过程中排除了一些记录,并且对数据处理和报告过程中的变化缺乏了解。该公司无法对已经失效的数据提供任何解释。


关于作者

问题动态

发布时间
2023-10-26 22:45
更新时间
2023-10-26 22:45
关注人数
1 人关注

相关问题

国际多中心临床试验,纳入中国数据,作为在国外上市时的临床资料,那么在中国上市时,不再论述人种差异,直接提交这份试验资料是否可行?
工艺验证数据是第3类数据---因此,不需要审计追踪审核。但是否需要对验证测量数据生成情况进行审核呢?
《用于罕见病防治医疗器械注册审查指导原则》的临床前研究要注意什么?
ERP系统,验证时在测试环境中进行,测试完成后,测试数据是否需要保留?
企业何时提出医疗器械优先审查?
"数据生命周期"。在检查报告数据和处理过的信息的完整性和准确性时,应考虑哪些风险?
《用于罕见病防治医疗器械注册审查指导原则》的沟通交流有哪些要求?
为什么外用制剂都控制铜绿假单胞菌和金黄色葡萄球菌?
使用磁珠保藏管保存质控菌株,加入菌液摇匀后为什么要吸干菌液?
如果生产区域如API生产的设施,混合器、灌装线具有可变参数,有什么办法处理其数据/系统分类,以及审核的程度和时间间隔?